Cargando…

MicroRNA and Hemostasis Profile of Carotid Atherosclerosis

Carotid atherosclerosis (CA) is an important risk factor for ischemic stroke. We described the miRNA and hemostasis profile of patients with moderate and advanced stages of carotid atherosclerosis and elucidated potential correlations with hemostatic activation. A prospective case-control study incl...

Descripción completa

Detalles Bibliográficos
Autores principales: Raskurazhev, Anton A., Kuznetsova, Polina I., Shabalina, Alla A., Tanashyan, Marine M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9500617/
https://www.ncbi.nlm.nih.gov/pubmed/36142883
http://dx.doi.org/10.3390/ijms231810974
_version_ 1784795264283836416
author Raskurazhev, Anton A.
Kuznetsova, Polina I.
Shabalina, Alla A.
Tanashyan, Marine M.
author_facet Raskurazhev, Anton A.
Kuznetsova, Polina I.
Shabalina, Alla A.
Tanashyan, Marine M.
author_sort Raskurazhev, Anton A.
collection PubMed
description Carotid atherosclerosis (CA) is an important risk factor for ischemic stroke. We described the miRNA and hemostasis profile of patients with moderate and advanced stages of carotid atherosclerosis and elucidated potential correlations with hemostatic activation. A prospective case-control study included 61 patients with evidence of carotid atherosclerosis (via ultrasound). The study population was divided into groups depending on the degree of carotid artery stenosis: 60% or more (advanced) and <60% (moderate). All patients underwent the following blood tests: general blood test, hemostatic parameters and microRNA. Extraction of microRNA was performed using Leukocyte RNA Purification Kit (NORGEN Biotec Corp., Thorold, ON, Canada); miRNA quantification was performed via RT-PCR. Statistical analysis was performed in R programming language (v. 4.1.0) using RSudio. MicroRNA expression profile was different depending on CA degree. MiR-33a-5p/3p levels were higher in patients with ≥60% carotid stenosis (42.70 and 42.45 versus 38.50 and 38.50, respectively, p < 0.05). Almost complete separation can be visualized with the levels of miR-126-5p: 9.50 in the moderate CA group versus 5.25 in the advanced CA (p < 0.001). MiR-29-5p was higher in the moderate CA group: 28.60 [25.50;33.05] than in advanced CA group: 25.75 [24.38;29.50] (p = 0.086); miR-29-3p was also higher in the moderate CA group: 10.36 [8.60;14.99] than in advanced CA group: 8.46 [7.47;10.3] (p = 0.001). By-group pairwise correlation analyses revealed at least three clusters with significant positive correlations in the moderate CA group: miR-29-3p with factors V and XII (r = 0.53 and r = 0.37, respectively, p < 0.05); miR-21-5p with ADAMTS13, erythrocyte sedimentation rate and D-dimer (r = 0.42, r = 0.36 and r = 0.44, respectively, p < 0.05); stenosis degree with miR-33a-5p/3p and factor VIII levels (r = 0.43 (both) and r = 0.62, respectively, p < 0.05). Hemostasis parameters did not reveal significant changes in CA patients: the only statistically significant differences concerned factor VIII, plasminogen and (marginally significant) ADAMTS-13 and protein C. Down-regulation of miR-126-5p expression has been identified as a promising biomarker of advanced carotid atherosclerosis with high specificity and sensitivity. Correlation cluster analysis showed potential interplay between miRNAs and hemostatic activation in the setting of carotid atherosclerosis.
format Online
Article
Text
id pubmed-9500617
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-95006172022-09-24 MicroRNA and Hemostasis Profile of Carotid Atherosclerosis Raskurazhev, Anton A. Kuznetsova, Polina I. Shabalina, Alla A. Tanashyan, Marine M. Int J Mol Sci Article Carotid atherosclerosis (CA) is an important risk factor for ischemic stroke. We described the miRNA and hemostasis profile of patients with moderate and advanced stages of carotid atherosclerosis and elucidated potential correlations with hemostatic activation. A prospective case-control study included 61 patients with evidence of carotid atherosclerosis (via ultrasound). The study population was divided into groups depending on the degree of carotid artery stenosis: 60% or more (advanced) and <60% (moderate). All patients underwent the following blood tests: general blood test, hemostatic parameters and microRNA. Extraction of microRNA was performed using Leukocyte RNA Purification Kit (NORGEN Biotec Corp., Thorold, ON, Canada); miRNA quantification was performed via RT-PCR. Statistical analysis was performed in R programming language (v. 4.1.0) using RSudio. MicroRNA expression profile was different depending on CA degree. MiR-33a-5p/3p levels were higher in patients with ≥60% carotid stenosis (42.70 and 42.45 versus 38.50 and 38.50, respectively, p < 0.05). Almost complete separation can be visualized with the levels of miR-126-5p: 9.50 in the moderate CA group versus 5.25 in the advanced CA (p < 0.001). MiR-29-5p was higher in the moderate CA group: 28.60 [25.50;33.05] than in advanced CA group: 25.75 [24.38;29.50] (p = 0.086); miR-29-3p was also higher in the moderate CA group: 10.36 [8.60;14.99] than in advanced CA group: 8.46 [7.47;10.3] (p = 0.001). By-group pairwise correlation analyses revealed at least three clusters with significant positive correlations in the moderate CA group: miR-29-3p with factors V and XII (r = 0.53 and r = 0.37, respectively, p < 0.05); miR-21-5p with ADAMTS13, erythrocyte sedimentation rate and D-dimer (r = 0.42, r = 0.36 and r = 0.44, respectively, p < 0.05); stenosis degree with miR-33a-5p/3p and factor VIII levels (r = 0.43 (both) and r = 0.62, respectively, p < 0.05). Hemostasis parameters did not reveal significant changes in CA patients: the only statistically significant differences concerned factor VIII, plasminogen and (marginally significant) ADAMTS-13 and protein C. Down-regulation of miR-126-5p expression has been identified as a promising biomarker of advanced carotid atherosclerosis with high specificity and sensitivity. Correlation cluster analysis showed potential interplay between miRNAs and hemostatic activation in the setting of carotid atherosclerosis. MDPI 2022-09-19 /pmc/articles/PMC9500617/ /pubmed/36142883 http://dx.doi.org/10.3390/ijms231810974 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Raskurazhev, Anton A.
Kuznetsova, Polina I.
Shabalina, Alla A.
Tanashyan, Marine M.
MicroRNA and Hemostasis Profile of Carotid Atherosclerosis
title MicroRNA and Hemostasis Profile of Carotid Atherosclerosis
title_full MicroRNA and Hemostasis Profile of Carotid Atherosclerosis
title_fullStr MicroRNA and Hemostasis Profile of Carotid Atherosclerosis
title_full_unstemmed MicroRNA and Hemostasis Profile of Carotid Atherosclerosis
title_short MicroRNA and Hemostasis Profile of Carotid Atherosclerosis
title_sort microrna and hemostasis profile of carotid atherosclerosis
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9500617/
https://www.ncbi.nlm.nih.gov/pubmed/36142883
http://dx.doi.org/10.3390/ijms231810974
work_keys_str_mv AT raskurazhevantona micrornaandhemostasisprofileofcarotidatherosclerosis
AT kuznetsovapolinai micrornaandhemostasisprofileofcarotidatherosclerosis
AT shabalinaallaa micrornaandhemostasisprofileofcarotidatherosclerosis
AT tanashyanmarinem micrornaandhemostasisprofileofcarotidatherosclerosis